Sickness behavior is a cluster of symptoms that occur as a response to an infection and alterations in the inflammatory response. Under normal circumstances, sickness behavior is fully reversible once the pathogen has been cleared. Aging and chronic illness such as heart failure are associated with enhanced inflammatory activity that lasts for a long duration and no longer represents an adaptive response. The aim of this study was to explore whether inflammation mediates the relationship between impaired cardiac function and a symptom cluster including anhedonia, fatigue, and sleepiness, which might represent sickness behavior in community-dwelling elders. Structural equation modeling (SEM) showed that the factor impaired cardiac function (i.e., N-terminal fragment of pro-brain natriuretic peptide, left ventricular ejection fraction, and the heart failure medications angiotensin converting enzyme inhibitor, angiotensin receptor blockade, b-blocker, and diuretics) was associated with both inflammation (i.e., C-reactive protein; b ¼ .26) and the symptom cluster (b ¼ .31). Inflammation had a significant direct, but smaller, association with the symptom cluster (b ¼ .21). By this pathway, inflammation also mediated an indirect association between impaired cardiac function and the symptom cluster (b ¼ .05). Including creatinine, blood glucose, ischemic heart disease, previous and current tumor, respiratory disease, age, and body mass index in the SEM model did not change these associations. Our results imply that some aspects of the symptom panorama in elderly individuals with impaired cardiac function or heart failure could represent sickness behavior.
failure can be defined as a reduced left ventricular ejection fraction (LVEF) below 50%. The measurement of LVEF is preferably performed with echocardiography and based on the end diastolic volume minus the end systolic volume divided by the end diastolic volume. Another commonly used measure of heart failure is N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP; McMurray et al., 2012) . This peptide provides information about myocardial wall tension and is sensitive to subtle alterations in left ventricular filling pressures (Alehagen, Lindstedt, Eriksson, & Dahlstrom, 2003) . Treatment of heart failure and/or impaired cardiac function with angiotensin-converting enzyme inhibitors (ACE-I), angiotensin receptor blockade (ARB), b-blockers, and diuretics has proved to reduce symptoms such as edema and improve cardiac function (McMurray et al., 2012) . In heart failure, inflammation may be due to myocardial tissue injury and impairment of cardiac function with hemodynamic overload and/or underperfusion of systemic tissues (Pasic et al., 2003) as well as gut wall edema (Sandek et al., 2010) . Impaired kidney function, diabetes, obesity, respiratory disease, previous or current tumor, and ischemic heart disease (IHD) are comorbid conditions associated with heart failure (McMurray et al., 2012) and inflammation (Al-shair et al., 2011; Bondia-Pons, Ryan, & Martinez, 2012; Bower, Ganz, Aziz, & Fahey, 2002; Ormstad, Aass, Amthor, Lund-Sorensen, & Sandvik, 2011; Rosner, Ronco, & Okusa, 2012) and are, therefore, possible causes of sickness behavior. Inflammation seems to speed the progression of impaired cardiac function and is associated with a poorer prognosis (Anand et al., 2005; Maeda et al., 2000; Tsutamoto et al., 1998) .
In patients with chronic heart failure, fatigue, anhedonia/ depression, and sleepiness are common (Brostrom & Johansson, 2005; Johansson, Dahlstrom, & Alehagen, 2007) . To our knowledge, however, no prior studies exploring the association between inflammation and this symptom cluster have been conducted in adults with heart failure. Some studies have found that depressive symptoms are associated with inflammation (Johansson et al., 2011; Wirtz et al., 2008) . But none of these prior studies have analyzed this particular symptom cluster as a contributor to the inflammatory response. Such a symptom cluster may stem from an inflammatory response initiated by impaired cardiac function and therefore may be evidence of sickness behavior in heart failure patients. We, therefore, sought to investigate whether inflammation mediates the relationship between impaired cardiac function and the symptom cluster comprising anhedonia, sleepiness, and fatigue in a sample of community-dwelling older adults. A positive finding would suggest that this cluster of symptoms represents sickness behavior and could have important implications for the treatment of elderly individuals with impaired cardiac function.
Method Participants
The sample was derived from the epidemiological CoroKind study and has been described previously (Alehagen, Goetze, & Dahlstrom, 2007; Johansson, Alehagen, Svanborg, Dahlstrom, & Brostrom, 2009 ). The initial study took place between 1998 and 2000. All included subjects were aged 65-82 years and lived in a rural community with 10,300 inhabitants in the southeast of Sweden. Investigators for the parent study invited all inhabitants in this age span to clinical and echocardiographic examinations. Of the 1,130 eligible individuals in the population, 876 agreed to participate (participation rate 78%). From January 2003 to June 2005 investigators again contacted the cohort and invited them to repeat the clinical and echocardiographic examination. A total of 675 subjects agreed to participate. The reasons for not participating were death (12%), having moved to nursing homes or other parts of Sweden (3%), declined (7%), or not showing up to the appointment (1%). The Regional Ethical review board of Linköping, Sweden, approved the study protocol.
Clinical Examination
A cardiologist took a patient history and performed a clinical examination for all participants. Diabetes mellitus was defined as ongoing treatment or fasting blood glucose !7 mmol/L. Hypertension was defined as a previous diagnosis of high blood pressure or a measured blood pressure of more than 140/90 mm Hg. IHD was defined as history of angina pectoris and/or myocardial infarction. Respiratory disease was established if the participant had a diagnosis or was undergoing treatment for chronic pulmonary disease or asthma. Previous or current tumor was defined by history. Cardiac function was assessed with Doppler echocardiography (Accuson XP-128c). Systolic function was divided semiquantitatively by visual estimation into three classes: normal systolic function corresponded to an LVEF !50%; mildly impaired systolic function, an LVEF 49-40%; and at least moderately impaired systolic function, an LVEF < 40%. In the present study, we also used N-terminal fragment of proBNP (NT-proBNP) as a measure of impaired cardiac function. All clinical examinations were based on the European Society of Cardiology's guidelines for treatment of heart failure (McMurray et al., 2012) , which specify that echocardiography and NT-proBNP are important objective examinations to establish impairment of systolic function. High-sensitivity C-reactive protein (CRP) was used as a routine marker of inflammation.
Blood Sampling
Blood samples were collected using ethylenediaminetetraacetic acid (EDTA) vials while the patients were at rest in a supine position. The vials were chilled on ice before centrifugation at 3000 g, 4 C, and then frozen at À70 C. No sample was thawed more than twice. NT-proBNP was measured using an electrochemiluminesence immunoassay (Elecsys 2010, Roche Diagnostics, Mannheim, Germany). Coefficient of variation was 4.8% at 26 pmol/L and 2.1% at 503 pmol/L (n ¼ 70). CRP was analyzed using latex-enhanced turbidimetric immunoassay (Roche Diagnostics GmbH, Vienna, Austria) with a lower detection limit of 0.03 mg/L and coefficient of variation of 1.7%.
Instruments
For the sickness behavior symptom cluster, a combination of three instruments was used. The Hospital Anxiety Depression scale (HADS) measures the anhedonic aspects of depression (depressed, sad mood, and loss of interest or pleasure) and was therefore used as a measure of anhedonia (Zigmond & Snaith, 1983) . Researchers have used the HADS in different types of settings (e.g., community care, primary care, and hospital wards) and patient groups (Bjelland, Dahl, Haug, & Neckelmann, 2002) and have found it to be a reliable tool. Scores from the seven depression items range from 0 to 21, with higher scores indicating anhedonia (Zigmond & Snaith, 1983) . Reliability for the HADS has been found to be 0.82 (Bjelland et al., 2002) .
Fatigue was measured using the vitality scale of the SF-36. The scores range from 0 to 100, with a higher score indicating higher levels of energy (Ware & Sherbourne, 1992) . Researchers have used the vitality scale of the SF-36 in studies examining the association between fatigue and inflammation in patients with breast cancer (Bower et al., 2002; Collado-Hidalgo, Bower, Ganz, Cole, & Irwin, 2006) . Reliability of the vitality (i.e., fatigue) scale of the SF-36 has been found to exceed 0.80 (Sullivan, Karlsson, & Ware, 1995) .
Sleepiness was measured with a single item (i.e., How great are the problems you have with sleepiness during the day?) from the Uppsala Sleep Inventory (USI; Liljenberg, Almqvist, Hetta, Roos, & Agren, 1988) . The respondents rated their problems on a 5-point Likert-type scale ranging from no problems to very great problems. Investigators have previously used the whole USI in surveys of both younger and elderly people, as well as patients with heart failure (Brostrom, Stromberg, Dahlstrom, & Fridlund, 2004; Mallon, Broman, & Hetta, 2002; Mallon & Hetta, 1997) . We have used this single-item measure of sleepiness in previous studies (Johansson et al., 2009 ).
Analytic Strategy and Statistical Analysis
We used descriptive statistics and structural equation modeling (SEM) to analyze the data. The SEM analysis was inspired by Bower's (2007) model, which describes a potential associations among cancer and cancer treatment, inflammation, and cancer-related fatigue. In that model, cancer and its treatment activate the inflammatory network which, in turn, leads to symptoms of fatigue. In our model, we included ''impaired cardiac function,'' ''inflammation,'' and ''sickness behavior.'' According to the inflammation hypothesis of heart failure, we drew the direction of the path in the SEM from impaired cardiac function toward inflammation (Pasic et al., 2003) . We also drew paths from ''inflammation'' to ''sickness behavior,'' and from ''impaired cardiac function'' to ''sickness behavior.'' The latent variable ''impaired cardiac function'' included three classes of LVEF and the cardiac biomarker NT-proBNP. We also included cardiovascular medications used for patients with heart failure, namely ACE-I, ARB, b-blockers, and diuretics, because they can improve LVEF and decrease edema and may thereby decrease inflammation. The latent factor ''inflammation''
included plasma values of CRP. As sickness behavior can be seen as a symptom cluster (Myers, 2008) , we amalgamated the variables anhedonia, fatigue, and sleepiness into one latent factor labeled ''sickness behavior.'' To explore a possible influence of age and important comorbidities on the relationships among impaired cardiac function, inflammation, and sickness behavior, we examined the impact of creatinine (i.e., marker of impaired kidney function), blood glucose (i.e., a marker of diabetes), body mass index (i.e., marker of obesity), respiratory disease, previous or current tumor, and IHD (the latter three were all yes/no) in the basic SEM model. We chose these comorbidities because of their known association to impairment of cardiac function and/ or inflammation and/or sickness behavior.
We tested categorical variables with chi-square tests and analyzed continuous variables with Student's t-test or Mann-Whitney U test, depending on distribution of normality. We used SEM to explore the relationships between impaired systolic function, inflammation, and sickness behavior. In the SEM analysis, by means of PRELIS analysis, we used polychoric correlations to derive estimates of covariance. Polychoric correlations estimate the correlations between latent estimates of the measured variables and assume a normal distribution of bivariate variables. To obtain a normal distribution CRP, we logarithmically transformed plasma creatinine and NT-proBNP.
We derived associations in the SEM using maximum likelihood methods and we describe them with their standardized coefficients. To assess goodness of fit we used the chi-square value, the root mean square error of approximation (RMSEA), and Comparative Fit Index (CFI) to indicate how well the model fit in the population of community-dwelling elderly. For the chi-square test, a high value and a significant test indicate a poor fit, but sample size influences these parameters. An overall RMSEA below 0.06 and a CFI > 0.95 indicates a good fit (Schreiber, 2008) . We performed descriptive statistical analyses with Statistical Package for the Social Sciences (SPSS) 18.0 (IBM, SPSS, Chicago, IL) and SEM analyses with LISREL (Scientific Software International, Lincolnwood, IL). We considered a p < .05 in the SPSS analyses and a t-value of !1.96 in the LISREL analyses to be significant.
Results
Of the 675 participants we investigated, 627 (93%) had follow-up data on cardiac function, inflammation, anhedonia, fatigue, and sleepiness (i.e., sickness behavior). We show the characteristics of the sample in Table 1 .
The covariance matrix used in the SEM analyses appears in Table 2 . Figure 1 describes the basic SEM model of the associations among impaired cardiac function, inflammation, and sickness behavior. The fit of the model was good (w 2 ¼ 30.5, p ¼ .10; RMSEA ¼ 0.025, CFI ¼ 0.99), demonstrating that impaired cardiac function had significant direct associations with inflammation (b ¼ .26) and sickness behavior (b ¼ .31). Inflammation also had a significant direct association with sickness behavior (b ¼ .21), though this association was smaller than that between inflammation and impaired cardiac function. Inflammation partially mediated the relationship between impaired cardiac function and sickness behavior (b ¼ .05). The total effect of impaired cardiac function on sickness behavior was b ¼ .36.
To examine the influence of age, body mass index, plasma creatinine, blood glucose, respiratory disease, previous or current tumor, and IHD on the associations among impaired cardiac function, inflammation, and sickness behavior, we tested new SEM models for each variable. Age (b ¼ .39), blood glucose (b ¼ .32), respiratory disease (b ¼ .17), plasma creatinine (b ¼ .58), and IHD (b ¼ .80) were all significantly associated with impaired cardiac function; in contrast, body mass index and previous or current tumor were significantly associated with inflammation (b ¼ .28 and b ¼ .22). However, none of these new models revealed any major impact of these variables on the associations among impaired cardiac function, inflammation, and sickness behavior. The strong associations we found between both plasma creatinine and IHD and impaired cardiac function is a logical finding since these variables can be seen as part of the pathophysiology of heart failure. In a subsequent analysis, we added IHD and plasma creatinine into the latent variable impaired cardiac function and explored whether either variable had any impact on the associations among impaired cardiac function, inflammation, and sickness behavior. The fit of this model was also good (w 2 ¼ 43.9, p ¼ .12; RMSEA ¼ 0.022, CFI ¼ 0.99). However, this model did not add any new information because all associations (b) were of the same magnitude as those found in the initial model (Figure 1) . In this new model, the indirect effect between impaired cardiac function and sickness behavior (b ¼ .05) mediated by inflammation also remained unchanged.
Discussion
In the present study, we explored the hypothesis that a cluster of symptoms commonly found in elderly individuals with impaired cardiac function, including anhedonia, sleepiness, and fatigue, are associated with inflammation and thus, may be defined as sickness behavior. No previous study has investigated the possibility that this particular cluster of symptoms might be evidence of an inflammatory component in elders with impaired cardiac function or heart failure. Investigators have found inflammation to be associated with depression or fatigue in patients with cancer (Bower et al., 2002; Bower et al., 2011; Orre et al., 2009 ). Heart failure is another condition that researchers have found to be associated with an activated inflammatory network (Torre-Amione et al., 1996) , depression (Lesman-Leegte, Jaarsma, Sanderman, Linssen, & van Veldhuisen, 2006), sleepiness (Brostrom et al., 2004) , and fatigue (Falk, Patel, Swedberg, & Ekman, 2009 ). In recent studies, investigators have found inflammation to be associated with depression in patients with heart failure (Johansson et al., 2011; Wirtz et al., 2009) . However, these studies have only evaluated depression or fatigue separately rather than combined as a symptom cluster.
For nurses, knowledge about the underlying mechanisms of heart failure symptoms may be important for the development of treatment strategies. Our SEM models illustrate that impaired cardiac function had a direct association with the symptom cluster in question and with inflammation. However, we also found inflammation to be directly associated with the symptom cluster, and importantly, inflammation mediated a partial indirect association between impaired cardiac function and the symptoms. Aging and comorbidity can increase inflammation and hence trigger sickness behavior (Hunt et al., 2010a) . In our analysis of individuals with a mean age of 78 years, age and comorbid conditions were associated with impaired cardiac function and inflammation, but the presence of these variables did not change the associations found in the principal SEM model. These findings suggest that inflammation mediates the symptom response in elders with impaired cardiac function.
From a clinical perspective, suffering from sickness behavior may lead to less capability in the performance of daily activities. Patients may integrate sickness behavior into their self-image with words such as tiredness, loss of interest, and laziness. To reduce this psychological burden, nurses can explain that these symptoms can originate from biological changes due to an impaired cardiac function.
From a biophysical perspective, several mechanisms stemming from impairment of cardiac function can lead to inflammation and thereby to sickness behavior, including underperfusion of systemic tissue and changes in the cardiac endocrine function such as increased secretion of brain natriuretic peptides (Clerico, Giannoni, Vittorini, & Passino, 2011; Pasic et al., 2003) . Another potential mechanism is increased permeability of the gut wall due to edema, which can induce translocation of gram-negative enterobacteria and secretion of endotoxin (i.e., lipopolysaccharide [LPS]), a potent stimulus of immune activation (Maes, Mihaylova, & Leunis, 2007) . Edematous patients with severe heart failure have decreased intestinal absorption and higher plasma concentrations of LPS, tumor necrosis factor alpha (TNF-a), and TNF-receptors 1 and 2 compared to nonedematous heart failure patients and healthy controls (Sandek et al., 2010) . Gut wall edema can delay the absorption of medications and could hypothetically be a sign of a more treatment-resistant patient or of a patient with more severe heart failure and a worse prognosis.
Researchers have not investigated the impact of sickness behavior in patients with heart failure. However, Ekman et al. (2005) found that fatigue predicted worsening heart failure. Investigators have found both depression (Johansson et al., 2007; Lesman-Leegte et al., 2009; Sherwood et al., 2007) and fatigue (Smith, Kupper, de Jonge, & Denollet, 2010) to be associated with mortality. Nurses should be aware of these critical pathophysiological signs of sickness behavior and therefore observant of their occurrence among elderly patients with heart failure.
In our model, pharmacological treatment for heart failure (i.e., ACE-I/ARB, b-blockers, and diuretics) was a part of the factor designated as impaired cardiac function. Despite the potential anti-inflammatory secondary effects of these cardiovascular medications (i.e., improved LVEF and cardiac output, decreased edema, and decreased immune activation), inflammation mediated some of the association between impaired cardiac function and sickness behavior. This finding suggests that other medications or nonpharmacological interventions with anti-inflammatory properties are needed to treat sickness behavior. Clinical trials investigating treatment approaches for sickness behavior are lacking. In the sertraline against depression and heart disease in chronic heart failure (SADHART-CHF) trial, selective serotonin reuptake inhibitors (SSRI) were not superior to placebo for decreasing depression in heart failure patients (O'Connor et al., 2010) . In a substudy of the same trial, researchers found that those patients whose depression did not improve from baseline levels, irrespective of SSRI or placebo, had more somatic/affective symptoms at baseline (Jiang et al., 2011) . Continuing depression suggests a symptom profile that could correspond with sickness behavior. It is therefore possible that depression as a symptom in sickness behavior in heart failure may be less responsive to antidepressant therapy than depression alone. Statins have anti-inflammatory effects in patients with coronary heart .26 .21
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disease. Interestingly, in a retrospective analysis of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) study, statins had favorable effects on cardiovascular deaths, all-cause mortality, and hospitalizations in a subgroup of patients with evidence of increased inflammatory activity (plasma value of CRP !2.0 mg/L) at baseline (McMurray et al., 2009) . Sickness behavior was not included as an outcome in the CORONA trial, but these results imply that statins could be useful in heart failure patients with sickness behavior.
Other approaches to decreasing inflammation include lifestyle changes focusing on anhedonia, fatigue, and sleepiness. Studies suggest that exercise programs can decrease inflammation in non-heart failure populations (Pinto et al., 2012) and in heart failure patients (Adamopoulos et al., 2001) . There is also evidence supporting the use of exercise programs for depressive disorders in patients without heart failure (Dirmaier et al., 2012) . Limited evidence also suggests that exercise programs can improve depressive symptoms in heart failure patients (Koukouvou et al., 2004; Milani, Lavie, Mehra, & Ventura, 2011) . Whether exercise can improve symptoms of sickness behavior remains to be elucidated.
A limitation of the present study is that it was not specifically designed to examine an association between inflammation and the symptom cluster. We only had one marker of inflammation in our analysis. We also had a limited number of variables that could be used as indicators of sickness behavior. Specifically, CRP was the only indicator of inflammation used. Although CRP, the marker of inflammation that we used, is commonly employed for this purpose, the association between inflammation and sickness behavior was small (b ¼ .21) and may have been underestimated due to the lack of more direct markers of chronic inflammation such as interleukin-1, interleukin-6, or TNF-a, the key cytokines triggering sickness behavior (Dantzer, 2006) . Another methodological explanation for the low correlations could be that we collected the data in this study from community-dwelling older adults who may not have been sufficiently ill to demonstrate more robust associations. However, in a previous study, the association between different inflammatory markers and fatigue in cancer patients rarely exceeded r ¼ .20, and the highest correlation was r ¼ .29 (Schubert, Hong, Natarajan, Mills, & Dimsdale, 2007) . A clinical reason for these low correlations could be that the symptoms included in the sickness behavior cluster (anhedonia, fatigue, sleepiness) are not only caused by inflammation but may also occur as a response to other stressors such as low socioeconomic status or bereavement (Cole & Dendukuri, 2003; Skobel et al., 2005) . Unfortunately, data on obstructive sleep apnea, cognitive impairment, lethargy, loss of appetite, hyperalgesia, and physical capacity, also known triggers of inflammation and hence possibly associated with sickness behavior, were not available for inclusion in the model. The associations between inflammation and sickness behavior may thus have been underestimated in the present study. Moreover, because of the cross-sectional study design, the associations presented in the SEM models cannot be interpreted as strict causal relationships.
In summary, we have shown that inflammation and impaired systolic function both were associated with a symptom cluster of anhedonia, fatigue, and sleepiness in community-dwelling older adults. Our results imply that this symptom cluster could represent sickness behavior in patients with heart failure. If future research supports these associations, they will point to the need to develop innovative intervention approaches for patients with heart failure and sickness behavior that address inflammation as well.
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